Detalhe da pesquisa
1.
A phase 3 double-blind study of the addition of tocilizumab vs placebo to cyclosporin/methotrexate GVHD prophylaxis.
Blood
; 137(14): 1970-1979, 2021 04 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33512442
2.
A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation.
Support Care Cancer
; 25(2): 607-613, 2017 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27738796
3.
Addition of interleukin-6 inhibition with tocilizumab to standard graft-versus-host disease prophylaxis after allogeneic stem-cell transplantation: a phase 1/2 trial.
Lancet Oncol
; 15(13): 1451-1459, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25456364
4.
High incidence of resistant breakthrough invasive fungal infections (IFD) in patients treated for acute gastrointestinal graft-versus-host disease (GI GVHD) following allogeneic haematopoietic cell transplantation.
Bone Marrow Transplant
; 57(11): 1712-1715, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35970876
5.
A 17-year-old girl with severe respiratory failure and circulatory shock.
Med J Aust
; 195(7): 414-5, 2011 Oct 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-21978351
6.
Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications.
PLoS One
; 8(10): e74744, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-24146744